INSUGEN 30/70 PENFILL 3 ML

How INSUGEN 30/70 PENFILL 3 ML Works

• INSUGEN 30/70 Penfill 3 ml is a premixed insulin formulation containing 30% rapid-acting soluble insulin and 70% intermediate-acting isophane insulin. This combination is designed to provide both a quick burst of insulin to cover mealtime glucose spikes and a sustained release to manage basal glucose levels throughout the day. The rapid-acting component, soluble insulin, starts working within 30 minutes of injection, helping to control blood sugar levels immediately after eating. It achieves its peak effect in 2-4 hours and lasts for up to 8 hours. The intermediate-acting component, isophane insulin, has a delayed onset of action, typically around 1-2 hours, peaks in 4-12 hours, and lasts for up to 18-24 hours, providing a longer duration of glucose control.
• When injected subcutaneously, INSUGEN 30/70 is absorbed into the bloodstream, where it facilitates the uptake of glucose by cells in the body, primarily in the liver, muscle, and fat tissues. Insulin binds to insulin receptors on these cells, triggering a cascade of intracellular events that lead to the translocation of glucose transporters (GLUT4) to the cell surface. These transporters enable glucose to enter the cells, where it can be used for energy or stored as glycogen in the liver and muscle, or as fat in adipose tissue. By promoting glucose uptake, insulin lowers blood glucose levels.
• In individuals with diabetes, the body either does not produce enough insulin (Type 1 diabetes) or cannot effectively use the insulin it produces (Type 2 diabetes). INSUGEN 30/70 helps to compensate for this deficiency by supplementing the body's own insulin supply. The premixed nature of INSUGEN 30/70 simplifies insulin therapy for many patients, as it reduces the need for multiple injections of different types of insulin. It offers a convenient way to manage blood glucose levels by providing a combination of immediate and sustained insulin action. Regular monitoring of blood glucose levels is crucial to ensure that the dosage of INSUGEN 30/70 is appropriately adjusted to meet individual needs. Factors such as diet, exercise, and stress can all affect blood glucose levels and insulin requirements.
• The 30/70 ratio in INSUGEN 30/70 refers to the proportion of rapid-acting to intermediate-acting insulin. This specific ratio is designed to mimic the natural insulin release pattern in the body, providing a balanced approach to glucose control. The rapid-acting component addresses the postprandial (after-meal) glucose surge, while the intermediate-acting component provides a basal level of insulin to maintain glucose levels between meals and during the night. By using a premixed insulin like INSUGEN 30/70, patients can achieve better glycemic control with fewer injections, improving adherence to their treatment plan and overall quality of life. It is important to note that individual responses to insulin can vary, and the optimal dosage and timing of injections should be determined by a healthcare professional based on the patient's specific needs and blood glucose monitoring results.
• Furthermore, it is important to understand the role of both insulin components. Soluble insulin, the 30% component, quickly lowers blood glucose after meals by allowing glucose to enter cells for energy or storage. Isophane insulin, the 70% component, acts as a background insulin, providing a steady supply of insulin to manage glucose levels when not eating. This combination reduces the need for multiple injections and provides a more balanced control of blood sugar levels. Proper use of INSUGEN 30/70 along with regular blood glucose monitoring and lifestyle adjustments, such as diet and exercise, can significantly improve blood sugar management and prevent complications associated with diabetes. Regular consultation with a healthcare provider is essential to adjust dosage and ensure optimal glycemic control.

Like all medicines, INSUGEN 30/70 PENFILL 3 ML can cause side effects, although not everybody gets them. **Common side effects (may affect up to 1 in 10 people):** * Hypoglycemia (low blood sugar): Sweating, dizziness, palpitations, hunger, tremor, anxiety, unusual tiredness or weakness, headache, confusion, difficulty concentrating, slurred speech, temporary visual disturbances. * Local reactions at the injection site: Redness, swelling, itching. **Uncommon side effects (may affect up to 1 in 100 people):** * Lipodystrophy: The fatty tissue under the skin at the injection site may shrink (lipoatrophy) or thicken (lipohypertrophy) if you inject insulin too often at the same site. * Edema: Swelling of ankles and feet may occur when you start using insulin or increase the dose. **Rare side effects (may affect up to 1 in 1,000 people):** * Allergic reactions: Generalized skin rash, itching, sweating, gastrointestinal upset, angioneurotic edema (swelling especially about the face, tongue or throat), difficulties in breathing, palpitation, fall in blood pressure. **Very rare side effects (may affect up to 1 in 10,000 people):** * Severe allergic reaction (anaphylactic reaction): Symptoms may include generalized skin reactions, angioedema, bronchospasm, hypotension and shock. This can be life-threatening. **Other possible side effects:** * Sodium retention: Insulin may cause sodium retention, leading to fluid retention and, in some cases, heart failure.

• If you miss a dose of INSUGEN 30/70, take it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and continue with your regular dosing schedule. Do not double your dose to make up for the missed one. Consult your doctor or diabetes educator for further guidance on managing missed doses to maintain optimal blood sugar control.

• Keep INSUGEN 30/70 PENFILL 3ML away from the reach of children and pets.
• Store INSUGEN 30/70 PENFILL 3ML in a refrigerator (2 - 8°C). Do not freeze.

• **Understand Your Insulin Type:** INSUGEN 30/70 is a premixed insulin containing 30% rapid-acting and 70% intermediate-acting insulin. This means it provides both immediate and sustained blood sugar control. It's crucial to understand how each component works to manage your blood sugar levels effectively throughout the day. Talk to your doctor about how INSUGEN 30/70 fits into your overall diabetes management plan.
• **Administer Correctly:** Always use a proper injection technique to ensure accurate dosing and absorption. Inject INSUGEN 30/70 subcutaneously (under the skin) as directed by your healthcare provider. Rotate injection sites within the same general area (e.g., abdomen, thigh, or upper arm) to prevent lipodystrophy (changes in fat tissue under the skin). Make sure to prime the pen before each injection, following the instructions provided in the pen's user manual, to remove any air bubbles and ensure accurate dosage.
• **Timing is Key:** Inject INSUGEN 30/70 approximately 30 minutes before a meal. This allows the rapid-acting component to start working as you begin to eat, preventing a post-meal blood sugar spike. Consistent timing is essential for predictable blood sugar control. Discuss with your doctor or diabetes educator the ideal timing of your injections relative to your meal schedule.
• **Monitor Blood Glucose Regularly:** Frequent blood glucose monitoring is vital when using insulin. Check your blood sugar levels before meals, two hours after meals, and at bedtime, as well as any other times recommended by your doctor. Keep a log of your blood sugar readings and any adjustments you make to your insulin dosage or diet. Share this information with your healthcare team to optimize your treatment plan. Recognizing patterns in your blood sugar levels will help you adjust your lifestyle for better control.
• **Be Prepared for Hypoglycemia:** Hypoglycemia (low blood sugar) is a potential side effect of insulin therapy. Always carry a source of fast-acting carbohydrates, such as glucose tablets, juice, or hard candies, to treat low blood sugar immediately. Learn to recognize the symptoms of hypoglycemia, which can include shakiness, sweating, dizziness, confusion, and rapid heartbeat. Inform your family, friends, and coworkers about your diabetes and how to help you if you experience severe hypoglycemia. Consider wearing a medical alert bracelet or carrying an ID card stating that you have diabetes.

• INSUGEN 30/70 PENFILL 3 ML interacts significantly with food intake. It's crucial to maintain consistency in meal timing and carbohydrate content. Skipping meals or unplanned changes in diet can lead to hypoglycemia (low blood sugar).
• Consuming alcohol while using INSUGEN 30/70 PENFILL 3 ML can also increase the risk of hypoglycemia. It's advisable to limit or avoid alcohol consumption.
• Be cautious of foods with high sugar or carbohydrate content, as they can affect blood sugar levels and require adjustments in insulin dosage. Always monitor your blood glucose levels regularly and consult your doctor for personalized dietary advice.